Developing and Feasibility Testing of a Brief Contact Intervention to Reduce Self-harm Repetition Through Co-design.

September 29, 2022 updated by: National Taiwan University Hospital
Suicide is a major public health issue. Repeated self-harm may lead to potential future suicide deaths. In addition, it may lead to substantial loss in medical costs. Recently, smartphones have been widely used. Researchers started to apply mobile health to support individuals with self-harm experiences and to combine brief contact interventions which require lower cost to reduce repeated self-harm. However, the research evidence remains sparse. Furthermore, self-harm behaviors might be influenced by different cultural contexts. There is a need to conduct local studies in Taiwan. The aim of this study is to establish a co-design team which includes service users and service providers, to collaboratively develop a text- and web-based brief contact intervention (BCI) to reduce repeated self-harm, and to evaluate the feasibility of the intervention.

Study Overview

Status

Recruiting

Detailed Description

Study objectives:

  1. To establish a co-design team and develop a brief contact intervention (BCI), including the content, frequency, settings, and outcome measures of the intervention.
  2. To evaluate the feasibility of BCI, including the feasibility of recruitment, required resources, the appropriateness of data collection, and the acceptability of the BCI.

Methods:

  1. In study 1, we will recruit 4-6 service users and 4-6 service providers respectively, and we will conduct focus groups to discuss the content of the BCI. We will conduct individual interviews with participants to explore their experiences and perspectives regarding their participation in the co-design team.
  2. In study 2, we will recruit 30 participants who have self-harm experiences to participate in the BCI. The BCI will be delivered through texts and web pages and will last around 5 months. The content of BCI will include caring messages, reminders of appointments, safety planning, volitional help sheet, and resources information. We will collect user engagement data and compare study outcomes (e.g., suicidal ideation and behaviors, brief symptom rating scale (BSRS), and mental well-being scale) before and after receiving the BCI. We will collect the participants' feedback regarding the BCI and evaluate the required resources to further revise the BCI.

Study Type

Interventional

Enrollment (Anticipated)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Taipei, Taiwan, 100
        • Recruiting
        • National Taiwan University Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged 20 years or over
  • Mentally and physically stable and able to participate in individual interviews and interventions
  • Able to communicate in Mandarin and provide written informed consent
  • Willing to be recorded during the interviews
  • Received medical treatments or aftercare due to self-harm experiences, including self-harm ideations, self-harm behaviors, suicidal ideations, and suicidal attempts.
  • Able to use the smartphone to access the internet

Exclusion Criteria:

  • Mental and physical states are unstable (e.g., unconscious, severe psychiatric symptoms, strong suicidal ideations with specific suicide plans) to complete the interviews and interventions according to the health professionals.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: BCI group
Participants will be asked to participate in a brief contact intervention and to evaluate its feasibility, including the feasibility of recruitment, intervention resources, the appropriateness of data collection, and the acceptance of the intervention.
The brief contact intervention (BCI) will send out text messages to the participants. The text messages will include caring messages, reminders of appointments, and a link to a web page. The web page is anticipated to include safety planning, volitional helpsheet, and resources information. The text messages are anticipated to send out to the participants on a weekly base for 6 weeks in a row, and then change to monthly reminders. The monthly reminders are anticipated to include caring messages, reminders of appointments, and invitations to encourage the participants to click the previous web links again. The monthly reminders are anticipated to send out to the participants three times in a row. In the final reminder, the participants will be told that this intervention is going to end. In total, the participants will receive 9 texts within 5 months.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The acceptability of the intervention to participants
Time Frame: within 6 months of study completion
The investigators will conduct face-to-face qualitative interviews to understand the acceptability of the intervention amongst participants.
within 6 months of study completion
The feasibility of intervention to participants
Time Frame: within 6 months of study completion
The investigators will conduct face-to-face qualitative interviews to understand the feasibility of intervention amongst participants.
within 6 months of study completion
Participant recruitment
Time Frame: through study completion, an average of 1 year
Recruitment: the proportion of participants who are eligible and invited actually consent to participate.
through study completion, an average of 1 year
Participant retention rate
Time Frame: 1 month
The proportion of participants who can be reached by in-person or phone contact at the 1 month follow-up.
1 month
Participant retention rate
Time Frame: 3 month
The proportion of participants who can be reached by in-person or phone contact at the 3 month follow-up.
3 month
Participant retention rate
Time Frame: 6 month
The proportion of participants who can be reached by in-person or phone contact at the 6 month follow-up.
6 month
Number of repeated self-harm episodes (self-report)
Time Frame: 1 month
Number of repeated self-harm episodes per person at 1 month after intervention based on self-report.
1 month
Number of repeated self-harm episodes (self-report)
Time Frame: 3 month
Number of repeated self-harm episodes per person at 3 month after intervention based on self-report.
3 month
Number of repeated self-harm episodes (self-report)
Time Frame: 6 month
Number of repeated self-harm episodes per person at 6 month after intervention based on self-report.
6 month
Number of repeated self-harm episodes (nationwide self-harm registry)
Time Frame: 1 month
Number of repeat self-harm episodes per person at 1 month after intervention recorded in the nationwide self-harm registry
1 month
Number of repeated self-harm episodes (nationwide self-harm registry)
Time Frame: 3 month
Number of repeat self-harm episodes per person at 3 month after intervention recorded in the nationwide self-harm registry
3 month
Number of repeated self-harm episodes (nationwide self-harm registry)
Time Frame: 6 month
Number of repeat self-harm episodes per person at 6 month after intervention recorded in the nationwide self-harm registry
6 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-efficacy and stages of change questionnaire
Time Frame: 1 month, 3 months, 6 months
Access participants' self-efficacy and stages of change in relation to suicide ideation and attempt at 1/3/6 month.
1 month, 3 months, 6 months
Help-seeking behavior questionnaire
Time Frame: 1 month, 3 months, 6 months
Assess the help-seeking behaviors of participants at 1/3/6 month.
1 month, 3 months, 6 months
Brief Symptom Rating Scale (BSRS)
Time Frame: 1 month, 3 months, 6 months
Briefly evaluate the psychological distresses of participants at 1/3/6 month. The total score ranges from 0 to 25. Categorized as "mild" with score 6-9, "moderate" with score 10-14, and "severe" with score more than 15.
1 month, 3 months, 6 months
The World Health Organisation- Five Well-Being Index (WHO-5)
Time Frame: 1 month, 3 months, 6 months
Measure the current mental wellbeing of participants at 1/3/6 month.
1 month, 3 months, 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Shu-Sen Chang, MD, MSc, PhD, National Taiwan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 19, 2022

Primary Completion (Anticipated)

July 1, 2024

Study Completion (Anticipated)

July 1, 2024

Study Registration Dates

First Submitted

August 31, 2022

First Submitted That Met QC Criteria

September 2, 2022

First Posted (Actual)

September 7, 2022

Study Record Updates

Last Update Posted (Actual)

September 30, 2022

Last Update Submitted That Met QC Criteria

September 29, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 202206137RINA

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicide and Self-harm

Clinical Trials on Brief contact intervention

3
Subscribe